Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at bevacizumab after surgery for melanoma skin cancer (AVAST-M)

Overview

Cancer types:

Melanoma, Skin cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at whether bevacizumab after surgery helped people live longer, or stopped melanoma coming back, in people who were at high risk of .

This trial was supported by Cancer Research UK.

Recruitment start: 18 July 2007

Recruitment end: 30 March 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Pippa Corrie

Supported by

Cambridge Cancer Trials Centre

Cambridge University Hospitals NHS Foundation Trust

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

NIHR Oxford Biomedical Research Centre

Roche

Warwick Medical School Clinical Trials Unit

Other information

This is Cancer Research UK trial number CRUK/06/014.

Last reviewed: 26 June 2017

CRUK internal database number: 702

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.